Common genetic variant on 14q13.3 contributes to thyroid cancer susceptibility: evidence based on 12 studies
Authors:
- 1 January 2015
- journal article
- research article
- Published by Springer Nature in Molecular Genetics and Genomics
- Vol. 290 (3) , 1125-1133
Abstract
Several genome-wide association studies on thyroid cancer (TC) have reported similar findings of a new susceptibility locus, 14q13.3. After that, a number of studies reported that rs944289 polymorphism at chromosome 14q13.3 has been implicated in TC risk. However, these studies have yielded inconsistent results. To investigate this inconsistency, we performed a meta-analysis of 12 studies involving a total of 7,598 TC cases, 53,613 controls, and 239 nuclear families for 14q13.3–rs944289 polymorphism to evaluate its effect on genetic susceptibility for TC. An overall random-effect per-allele OR of 1.30 (95 % CI 1.21–1.40, P < 10−5) was found for the polymorphism. Significant results were also observed for under dominant and recessive genetic models. In the subgroup analysis by ethnicity, we found similar significant results for both Caucasians (T allele: OR 1.29, 95 % CI 1.17–1.42, P < 10−5) and East Asians (T allele: OR 1.33, 95 % CI 1.18–1.49, P < 10−5). Further in stratified analyses according to study design and sample size, evidence of gene–disease association was also obtained. In addition, we found that rs944289 confers its risk, for both papillary thyroid carcinoma and follicular thyroid carcinoma when stratified by histological types of TC. Furthermore, our results on stratified analysis according to radiation exposure status showed an increased sporadic TC risk, while no associations were detected among radiation-related TCs for rs944289 polymorphism. Our result demonstrated that rs944289 polymorphism on 14q13.3 is a low penetrant risk factor for developing TC.Keywords
This publication has 46 references indexed in Scilit:
- The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor typeProceedings of the National Academy of Sciences, 2012
- Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24Journal of Medical Genetics, 2012
- Discovery of common variants associated with low TSH levels and thyroid cancer riskNature Genetics, 2012
- DICER1 Mutations in Familial Multinodular Goiter With and Without Ovarian Sertoli-Leydig Cell TumorsJAMA, 2011
- The PstI/RsaI and DraI polymorphisms of CYP2E1and head and neck cancer risk: a meta-analysis based on 21 case-control studiesBMC Cancer, 2010
- Genetic Heterogeneity in Human DiseaseCell, 2010
- Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populationsNature Genetics, 2009
- A Susceptibility Locus for Papillary Thyroid Carcinoma on Chromosome 8q24Cancer Research, 2009
- A second generation human haplotype map of over 3.1 million SNPsNature, 2007
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986